Methylene Blue for Refractory Shock in A Neonate
Ferhan Demirtaş, Yasemin Ezgi Köstekci, Aziz Kılıç, Engin Köse, Ömer Erdeve, Tanıl Kendirli, Begum Atasay · Zeitschrift für Geburtshilfe und Neonatologie · 2025 · Heft 06 · S. 450-452
Bibliografische Angaben
Zusammenfassung
Abstract Introduction Neonatal shock has a high mortality rate in neonates. New treatment approaches are being researched. Methylene blue (MB) may have the ability to enhance blood pressure but is rarely used on newborns. MB usage in a newborn with catecholamine-resistant shock who needed renal replacement therapy (RRT) due to hyperammonemia from an underlying urea cycle defect is presented here. Case presentation A 3050-g female neonate, born at 38 weeks' gestation, was admitted to our neonatal intensive care unit on the fourth postnatal day due to hyperammonemia and encephalopathy. She was in shock but did not…
